The optimal spatially-dependent control measures to effectively and economically eliminate emerging infectious diseases.

The optimal spatially-dependent control measures to effectively and economically eliminate emerging infectious diseases.

Publication date: Oct 07, 2024

Non-pharmaceutical interventions (NPIs) are effective in mitigating infections during the early stages of an infectious disease outbreak. However, these measures incur significant economic and livelihood costs. To address this, we developed an optimal control framework aimed at identifying strategies that minimize such costs while ensuring full control of a cross-regional outbreak of emerging infectious diseases. Our approach uses a spatial SEIR model with interventions for the epidemic process, and incorporates population flow in a gravity model dependent on gross domestic product (GDP) and geographical distance. We applied this framework to identify an optimal control strategy for the COVID-19 outbreak caused by the Delta variant in Xi’an City, Shaanxi, China, between December 2021 and January 2022. The model was parameterized by fitting it to daily case data from each district of Xi’an City. Our findings indicate that an increase in the basic reproduction number, the latent period or the infectious period leads to a prolonged outbreak and a larger final size. This indicates that diseases with greater transmissibility are more challenging and costly to control, and so it is important for governments to quickly identify cases and implement control strategies. Indeed, the optimal control strategy we identified suggests that more costly control measures should be implemented as soon as they are deemed necessary. Our results demonstrate that optimal control regimes exhibit spatial, economic, and population heterogeneity. More populated and economically developed regions require a robust regular surveillance mechanism to ensure timely detection and control of imported infections. Regions with higher GDP tend to experience larger-scale epidemics and, consequently, require higher control costs. Notably, our proposed optimal strategy significantly reduced costs compared to the actual expenditures for the Xi’an outbreak.

Open Access PDF

Concepts Keywords
China Control
December Costs
Infectious Dependent
Mitigating Developed
Pharmaceutical Diseases
Economic
Emerging
Gdp
Infections
Infectious
Interventions
Optimal
Outbreak
Population
Spatial

Semantics

Type Source Name
disease MESH emerging infectious diseases
disease MESH infections
disease MESH infectious disease
pathway REACTOME Infectious disease
disease IDO process
disease MESH COVID-19
pathway REACTOME Reproduction
disease MESH imported infections
disease IDO history
drug DRUGBANK Coenzyme M
disease IDO nucleic acid
disease IDO production
disease IDO infection
disease IDO pathogen
disease MESH emergency
disease IDO contact tracing
drug DRUGBANK Cysteamine
disease MESH community transmission
drug DRUGBANK Trestolone
drug DRUGBANK Dichloroisoproterenol
drug DRUGBANK Ademetionine
drug DRUGBANK Ranitidine
disease IDO algorithm
drug DRUGBANK Phenformin
disease MESH secondary infections
disease IDO susceptible population
drug DRUGBANK 2′-Deoxycytidine
disease MESH viral load
disease MESH viral shedding
disease MESH Bubonic plague
disease MESH influenza
drug DRUGBANK Isoxaflutole
drug DRUGBANK Aspartame
disease IDO intervention
drug DRUGBANK Tropicamide
disease MESH pneumonia
drug DRUGBANK Haloperidol
drug DRUGBANK Morpholinylmercaptobenzothiazole
drug DRUGBANK Carboxyamidotriazole
disease IDO virulence
disease MESH Thoracic Disease

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *